|
| | Issue Date | Title | Author(s) |
| 41 | 2016 | Quinoline-based small molecules as effective protein kinases inhibitors | Aly, Rasha M; Al-Ansary, Ghada H; Abou El Ella, Dalal A; Serya, Rabah ; Amira, M |
| 42 | 2016 | Design and synthesis of some new tri-substituted pyrazole derivatives as anticancer agents | Fahmy, Hoda H; Srour, Aladdin M; Khater, Mai A; El-Manawaty, May A; Serya, Rabah ; Ismail, Mohamed A |
| 43 | Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| 44 | 2015 | Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors | Serya, Rabah ; Abbas, Abeer Hussin; Ismail, Nasser Saad Mohamed; Esmat, Ahmed; Abou El Ella, Dalal |
| 45 | 2015 | Synthesis and in vitro antiproliferative activity of novel pyrazolo[3,4-d]pyrimidine derivatives | Abdou, Nermin S.; Serya, Rabah ; Esmat, Ahmed ; Tolba, Mai F.; Ismail, Nasser S. M.; Khaled A M Abouzid ; Nermin Samir |
| 46 | 2015 | Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Elrazaz, Eman ; Abou El Ella, Dalal ; Khaled A M Abouzid ; Rabah A.T. Serya ; Nasser S.M. Ismail |
| 47 | 2015 | Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents | Elsayed, NMY; Abou El Ella, D.A. ; Serya, RAT; Abouzid, Khaled ; Serya, Rabah |
| 48 | Dec-2014 | Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents | Abdel-Atty, Mona M; Farag, Nahla A; Kassab, Shaymaa E; Serya, Rabah ; Khaled A M Abouzid |
| 49 | Jun-2014 | Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers | Hussein, Mohammed M; Serya, Rabah ; Abdel Naby, Rana M; Al-Abd, Ahmed M; Saleh, Dalia O; El-Eraky, Wafaa I; Khaled A M Abouzid ; Abou El Ella, Dalal |
| 50 | Apr-2014 | Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents | Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Ahmed, Marawan; Wang, Feng; Khaled A M Abouzid |
| 51 | Jul-2013 | In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2 | Ahmed, Marawan; Sadek, Maiada M; Abouzid, Khaled ; Wang, Feng; Serya, Rabah |
| 52 | Mar-2013 | Assessment of new anti-HER2 ligands using combined docking, QM/MM scoring and MD simulation | Ahmed, Marawan; Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Wang, Feng; Khaled A M Abouzid |
| 53 | Mar-2013 | Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors | Elsayed, Mohamed S A; El-Araby, Moustafa E; Serya, Rabah ; El-Khatib, Ahmed H; Linscheid, Michael W; Khaled A M Abouzid |
| 54 | Dec-2012 | Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors | El-Araby, M E; Serya, Rabah ; Elbarbary, Elsayed M.E.; Khaled A M Abouzid |
| 55 | 15-Feb-2006 | Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists | Ismail, Mohamed A H; Aboul-Enein, Mohamed N Y; Abouzid, Khaled ; Serya, Rabah A T |
Loading...